Clinical trials
Phase 2/3 trials in Georgia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
34 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2011 | 1 |
| 2012 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 4 |
| 2021 | 5 |
| 2022 | 2 |
| 2023 | 5 |
| 2024 | 1 |
| 2025 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Recruiting | 9 |
| Terminated | 7 |
| Active, not recruiting | 5 |
| Unknown status | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Atom Therapeutics Co., Ltd | 2 |
| Forest Laboratories | 2 |
| Regeneron Pharmaceuticals | 2 |
| Swedish Herbal Institute AB | 2 |
| Theravance Biopharma | 2 |
| argenx | 2 |
| AtheroGenics | 1 |
| Balgrist University Hospital | 1 |
| BioNTech SE | 1 |
| CSL Behring | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| COVID-19 | 3 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Inflammatory Bowel Diseases | 3 |
| Breast Neoplasms | 2 |
| Colitis, Ulcerative | 2 |
| Crohn Disease | 2 |
| Gout | 2 |
| Infections | 2 |
| Lung Neoplasms | 2 |
| Tuberculosis | 2 |
Trials
Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.